Vital Signs - Reimbursement Cuts Slow Power Mobility Devices


USD 1,500

* Required Fields

USD 1,500


Be the first to review this product

This issue of Vital Signs, released on December 11, 2006, provides a strategic overview of the impact of reimbursement reductions by CMS on power mobility devices. Additionally, an emerging company profile is provided for Invacare Corporation, a leader in the development of home and long-term medical care products for the acute and non-acute care markets. Reimbursement and regulatory news from the FDA and CMS is also provided for the week of November 27 - December 1, 2006.

Table of Contents

Vital Signs - Reimbursement Cuts Slow Power Mobility DevicesVital Signs: 11 December 2006This week's issue:




Related Research

Release Date : 20-Nov-17

Region : North America

Release Date : 07-Nov-17

Region : North America

Release Date : 06-Nov-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.